Express Scripts does not cover Mounjaro for weight loss. Mounjaro is approved by the FDA only for type 2 diabetes, and Express Scripts formularies list it for that use alone. If you want tirzepatide (the active ingredient in Mounjaro) for weight management, the drug to ask about is Zepbound, which carries the FDA weight-loss indication and is covered by some, but not all, Express Scripts plans.
Why Mounjaro Is Treated as a Diabetes Drug
Mounjaro and Zepbound are the same molecule sold under two names. The FDA approved Mounjaro as an add-on to diet and exercise for blood sugar control in adults and children ten and older with type 2 diabetes.1FDA. Mounjaro Prescribing Information Zepbound carries a separate approval for chronic weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as hypertension, high cholesterol, type 2 diabetes, or sleep apnea.2FDA. Zepbound Prescribing Information
Insurers follow those labels. A Mounjaro prescription written for a patient without type 2 diabetes is off-label, and coverage for off-label weight-loss use of Mounjaro is “much less common and often excluded,” especially where the plan already lists Zepbound or another GLP-1 for obesity.3Drugs.com. Is Mounjaro Covered by Insurance or Medicare On the 2026 Express Scripts National Preferred Formulary, Mounjaro is a covered injectable for diabetes.4Express Scripts. 2026 National Preferred Formulary
Zepbound Is the Covered Tirzepatide for Weight Loss
Zepbound appears on the 2026 National Preferred Formulary and on the 2025 exclusion list as the preferred weight-loss alternative, replacing Saxenda.5Express Scripts. 2025 National Preferred Formulary Exclusions Preferred status on the national formulary is not the same as coverage on your plan. Express Scripts administers pharmacy benefits for thousands of employers and health plans, and each plan sponsor decides whether weight-loss drugs are included at all. As of late 2025, about 22% of employer-sponsored plans administered by Express Scripts covered GLP-1 medications for weight loss, compared with 59% of fully insured health plans.6Evernorth. GLP-1s Drive Historic Shift in Traditional Drug Trend
How to Check Your Plan
Log in at express-scripts.com or call the number on your prescription ID card. Express Scripts directs members to those two channels to confirm whether a specific GLP-1 is covered and at what cost.7Express Scripts. Are GLP-1s or Semaglutide Covered by My Plan
TRICARE Members
Express Scripts manages the TRICARE pharmacy benefit, and the rules are more specific. Mounjaro is covered for type 2 diabetes with prior authorization. Zepbound is covered for weight loss, but only for beneficiaries enrolled in TRICARE Prime or TRICARE Select.8Express Scripts. GLP-1 Medications for Diabetes and Weight Management
As of August 31, 2025, the Defense Health Agency ended weight-loss drug coverage for TRICARE beneficiaries outside Prime and Select, including TRICARE For Life. GLP-1s for type 2 diabetes stay covered for everyone.9Express Scripts. Changes to Your TRICARE Pharmacy Benefit TRICARE For Life users lost access to Wegovy and Zepbound; Mounjaro and Ozempic remain available for their diabetes indications.10MOAA. Weight Loss Drug Coverage Ends for TRICARE For Life Users
For TRICARE Prime or Select patients who do qualify, the Zepbound prior authorization requires a BMI of 30 or higher (or 27 or higher with a weight-related condition), at least six months of behavioral and dietary modification, and a three-month trial of a generic weight-loss medication such as phentermine without a 5% reduction in body weight. The step-therapy requirement can be waived for medical contraindications. Initial approval runs 12 months, and renewal requires documented loss of at least 5% of baseline weight.11Express Scripts. Zepbound Prior Authorization Criteria (TRICARE)
Medicare Members
Federal law bars Medicare Part D from paying for drugs used solely for weight loss, a prohibition in place since the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.12GoodRx. Does Medicare Cover Weight Loss Medication The Express Scripts Medicare PDP formulary lists “prescription drugs when used for anorexia, weight loss or weight gain” as excluded.13Express Scripts. Express Scripts Medicare PDP 2026 Formulary Mounjaro can be approved under an Express Scripts Medicare plan only when documented for type 2 diabetes.
In April 2025, the Trump Administration declined to finalize a proposed rule that would have allowed Part D coverage of obesity drugs.14Georgetown University. Policy Options to Cover Anti-Obesity Drugs The Treat and Reduce Obesity Act, which would lift the ban, was reintroduced as H.R. 4231 but has not passed.15Congress.gov. H.R. 4231 – Treat and Reduce Obesity Act of 2025
A limited workaround began in mid-2026. The CMS Medicare GLP-1 Bridge program covers Wegovy, Zepbound, and Foundayo for eligible beneficiaries at a $50 monthly copay, running through December 2027 outside the normal Part D benefit.16Medicare Rights Center. GLP-1 Weight Loss Drug Demonstration Begins July 202617GW School of Public Health. Latest Federal Developments18CMS. BALANCE Model
If You Want Coverage for Weight Loss
The most practical move on a commercial or employer plan is to ask your prescriber about Zepbound rather than Mounjaro. Same molecule, right label, no off-label hurdle. Check your formulary first through your Express Scripts account or the number on your ID card.7Express Scripts. Are GLP-1s or Semaglutide Covered by My Plan
If weight-loss drugs are excluded from your plan, you still have a few avenues:
- Have your prescriber submit a prior authorization. Most electronic reviews finish within two days.19Express Scripts. Coverage Reviews and Prior Authorization
- Appeal a denial using the instructions in your denial letter. For Medicare plans, the appeal window is 65 days, and Express Scripts must respond within seven days for standard requests or 72 hours for urgent ones.20Express Scripts. Coverage Review Redetermination
- Request a formulary exception. Your doctor submits a medical necessity form explaining why preferred alternatives will not work.21Express Scripts. Medical Necessity Form (TRICARE)
- Look at manufacturer savings. Eli Lilly offers a Mounjaro savings card that can lower cost to as little as $25 per fill for commercially insured patients, or roughly $499 per month without coverage. The card requires an FDA-approved use, which for Mounjaro means diabetes only.22Eli Lilly. Mounjaro Savings and Resources
Programs That Affect How You Fill a Covered GLP-1
Since June 2025, Express Scripts has routed home-delivery GLP-1 prescriptions through Evernorth EnGuide Pharmacy, a facility that dispenses only injectable GLP-1s including Mounjaro, Ozempic, Wegovy, and Zepbound. Retail pickup is still available.23Express Scripts. Evernorth EnGuide Pharmacy FAQ
Some employer plans that cover weight-loss GLP-1s require enrollment in a lifestyle program before the pharmacy will dispense. One version, EncircleRx with Omada, requires at least four weigh-ins and four app engagements each month. The program is free, but dropping out stops the fills.24Express Scripts. EncircleRx Patient FAQ
Express Scripts expanded its Patient Assurance Program in mid-2025 to include GLP-1 weight-loss drugs. On participating plans, the member copay is capped at $25 for a 34-day supply of Zepbound or Wegovy. A separate EncircleRx offering caps monthly costs at $200. Whether either applies to you depends on your plan sponsor opting in.25Evernorth. Express Scripts Expands Patient Assurance Program to Drive Affordability and Access for GLP-1s